CIK 0001411690
- Non-accelerated filer
- Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261756290
- Phone
- +1 858-888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF OPERATING OFFICER acquired 16,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 16,000 shares (grant or award)
- 4 Grant or award PRESIDENT AND CEO acquired 44,000 shares (grant or award)
- 4 Grant or award GENERAL COUNSEL acquired 14,500 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 16,000 shares (grant or award)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,081 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,229 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 3,073 shares (to pay taxes)
- 4 Shares withheld for taxes GENERAL COUNSEL gave up 402 shares (to pay taxes)
- 4 Grant or award Chief Operating Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 20,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 4 of 12 · 230 filings